Creative Medical Technology Holdings is Granted Patent on Mesenchymal Stem Cells for Female Infertility Pending Quayle Action

20 Apr 2020 - Yahoo News
Creative Medical Technology Holdings Inc. (OTC-CELZ) announced today receipt of a Quayle Action on its patent application 15/652213 entitled Methods for Treatment of Premature Ovarian Failure and Ovarian Aging using Regenerative Cells. The patent covers use of mesenchymal stem cells, a class of adult ...
usx:celz

---

Creative Medical Technology Holdings Announces IMMCELZ™ Adoptive Immunotherapy Product

11 Mar 2020 - Yahoo News
Creative Medical Technology Holdings announced today, what appears to be, the first personalized adoptive immunotherapy for treatment of autoimmunity, which the Company named "IMMCELZ™".
usx:celz

---

Creative Medical Technology Holdings, Inc. February 2020 Shareholder Update

13 Feb 2020 - Yahoo News
Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Orthopedics and Neurology using adult stem cell treatments, today announced business updates and plans for 2020.
usx:celz

---

Landmark Results for CaverStem® Procedure Published in Journal of Translational Medicine to Create Paradigm Shift in Treatment of Erectile Dysfunction

15 Jan 2020 - Yahoo News
Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today announced publication of clinical trial data on CaverStem® procedure for drug resistant erectile dysfunction (ED) patients ...
usx:celz

---

Creative Medical Technology Holdings, Inc. Discusses CaverStem and Other Patented Technology with The Stock Day Podcast

17 Oct 2019 - Yahoo News
Phoenix, Arizona--(Newsfile Corp. - October 17, 2019) - The Stock Day Podcast welcomed Creative Medical Technology Holdings, Inc. (CELZ) ("the Company"), a commercial stage biotechnology company currently trading on the OTC. CEO of the Company, Timothy Warbington, joined Stock Day host Everett ...
usx:celz

---

StemSpine® to Launch in the United States Following Successful Treatments Overseas with 12+ Months Data Showing Safety and Efficacy

17 Oct 2019 - Yahoo News
PHOENIX, Oct. 17, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today announced the successful clinical commercialization of StemSpine®. The company plans ...
usx:celz

---

October 2019 Shareholder Update: We Promised, We Delivered

10 Oct 2019 - Yahoo News
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company currently trading on the OTC under the ticker symbol CELZ. For further information about the company go to www.creativemedicaltechnology.com. For more information on our Caverstem® procedure please go to www.caverstem.com.
usx:celz

---

Creative Medical Technology Holdings Partners with Edge Media Network to Accelerate CaverStem® Adoption

11 Sep 2019 - Yahoo News
PHOENIX, Sept. 11, 2019 /PRNewswire/ -- Creative Medical Technology Holdings (OTC-CELZ) reported today it has signed an agreement with Edge Media Network to introduce CaverStem® to their community in an integrated campaign spanning web, email, social media, and in-person events. "We are excited to work ...
usx:celz

---

Creative Medical Technology Holdings Reports completion and submission of Clinical Trial Data on CaverStem® Procedure for Drug Resistant Erectile Dysfunction Patients

4 Sep 2019 - Yahoo News
In the submitted paper, a total of 40 patients were treated in the primary trial and 100 in the clinical registry. This signifies one of the largest clinical studies of a non-drug treatment for erectile dysfunction.
usx:celz

---

Creative Medical Technology Holdings, Inc. August 2019 Shareholder Update

5 Aug 2019 - Yahoo News
Due to stock price dropping below the price required to maintain status, the company has been moved from the OTCQB. Although the OTCQB is a highly desired status, we believe maintaining fully audited public disclosures is the important component.
usx:celz

---